| Sweden: Health system review A Anell, AH Glenngård, S Merkur, World Health Organization World Health Organization. Regional Office for Europe, 2012 | 747 | 2012 |
| Sweden: Health system review A Anell, AH Glenngård, S Merkur, World Health Organization World Health Organization. Regional Office for Europe, 2012 | 747 | 2012 |
| Leadership and governance in seven developed health systems PC Smith, A Anell, R Busse, L Crivelli, J Healy, AK Lindahl, G Westert, ... Health policy 106 (1), 37-49, 2012 | 210 | 2012 |
| Health systems in transition: Sweden AH Glenngård, F Hjalte, M Svensson, A Anell, V Bankauskaite, ... World Health Organization. Regional Office for Europe, 2005 | 176 | 2005 |
| International comparison of health care systems using resource profiles A Anell, M Willis Bulletin of the World Health Organization 78, 770-778, 2000 | 171 | 2000 |
| Swedish healthcare under pressure A Anell Health economics 14 (S1), S237-S254, 2005 | 163 | 2005 |
| Patient views on choice and participation in primary health care P Rosén, A Anell, C Hjortsberg Health policy 55 (2), 121-128, 2001 | 161 | 2001 |
| The public–private pendulum—patient choice and equity in Sweden A Anell New England Journal of Medicine 372 (1), 1-4, 2015 | 139 | 2015 |
| Choice and privatisation in Swedish primary care A Anell Health Economics, Policy and Law 6 (4), 549-569, 2011 | 133 | 2011 |
| The addition of S100B to guidelines for management of mild head injury is potentially cost saving O Calcagnile, A Anell, J Undén BMC neurology 16, 1-7, 2016 | 113 | 2016 |
| Deregulating the pharmacy market: the case of Iceland and Norway A Anell Health policy 75 (1), 9-17, 2005 | 108 | 2005 |
| Population preferences and choice of primary care models: a discrete choice experiment in Sweden J Hjelmgren, A Anell Health Policy 83 (2-3), 314-322, 2007 | 92 | 2007 |
| Samverkan i kommuner och landsting-en kunskapsöversikt A Anell, O Mattisson Studentlitteratur AB, 2009 | 88 | 2009 |
| Priority setting for pharmaceuticals: the use of health economic evidence by reimbursement and clinical guidance committees A Anell The European Journal of Health Economics, formerly: HEPAC 5, 28-35, 2004 | 86 | 2004 |
| Reimbursement and clinical guidance for pharmaceuticals in Sweden: do health-economic evaluations support decision making? A Anell, U Persson The European Journal of Health Economics 6, 274-279, 2005 | 81 | 2005 |
| Pharmacoeconomics and clinical practice guidelines: a survey of attitudes in Swedish formulary committees A Anell, P Svarvar Pharmacoeconomics 17, 175-185, 2000 | 80 | 2000 |
| Choice and participation in the health services: a survey of preferences among Swedish residents A Anell, P Rosén, C Hjortsberg Health policy 40 (2), 157-168, 1997 | 80 | 1997 |
| Public reporting on quality, waiting times and patient experience in 11 high-income countries B Rechel, M McKee, M Haas, GP Marchildon, F Bousquet, M Blümel, ... Health Policy 120 (4), 377-383, 2016 | 79 | 2016 |
| Revisiting out-of-pocket requirements: trends in spending, financial access barriers, and policy in ten high-income countries T Rice, W Quentin, A Anell, AJ Barnes, P Rosenau, LY Unruh, ... BMC health services research 18, 1-18, 2018 | 75 | 2018 |
| The monopolistic integrated model and health care reform: the Swedish experience A Anell Health Policy 37 (1), 19-33, 1996 | 75 | 1996 |
